FormWeb • amLODIPine-valsartan

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search by class Show Therapeutic Classes

Add Formweb to your mobile device

Android iOS

Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.

Huntsville Hospital

Approved Hospital Formulary

Suggestions or Corrections? Above and Beyond Nominations Formulary Request

Search results for:

amLODIPine-valsartan

amLODIPine-valsartan

Non-formulary Miscellaneous Programs
Therapeutic Interchange

Drug Name	Form	Strength	Formulary Unrestricted	Formulary Restricted	Non-Formulary	Interchange
Exforge	TABLET, ORAL	5 mg-160 mg, 5 mg-320 mg, 10 mg-160 mg, 10 mg-320 mg

Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

amLODIPine-valsartan (Exforge)

5 mg-160 mg
5 mg-320 mg
10 mg-160 mg
10 mg-320 mg

amLODIPine (Norvasc) AND valsartan (Diovan)

ONE 5 mg amLODIPine PLUS ONE 160 mg valsartan
ONE 5 mg amLODIPine PLUS ONE 320 mg valsartan
ONE 10 mg amLODIPine PLUS ONE 160 mg valsartan
ONE 10 mg amLODIPine PLUS ONE 320 mg valsartan

Reviewed: 8/28/07

Last updated: Mar. 21, 2026

Black Box Warning: Fetal Toxicity

This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.